These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1053 related items for PubMed ID: 26445379
1. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. Brahmi M, Thiesse P, Ranchere D, Mognetti T, Pinson S, Renard C, Decouvelaere AV, Blay JY, Combemale P. PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379 [Abstract] [Full Text] [Related]
3. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. Salamon J, Mautner VF, Adam G, Derlin T. Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104 [Abstract] [Full Text] [Related]
4. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ferner RE, Golding JF, Smith M, Calonje E, Jan W, Sanjayanathan V, O'Doherty M. Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395 [Abstract] [Full Text] [Related]
9. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study. Nishida Y, Ikuta K, Ito S, Urakawa H, Sakai T, Koike H, Ito K, Imagama S. Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792 [Abstract] [Full Text] [Related]
14. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Derlin T, Tornquist K, Münster S, Apostolova I, Hagel C, Friedrich RE, Wedegärtner U, Mautner VF. Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059 [Abstract] [Full Text] [Related]
15. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature. Yu YH, Wu JT, Ye J, Chen MX. World J Surg Oncol; 2016 May 10; 14():142. PubMed ID: 27159980 [Abstract] [Full Text] [Related]
17. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. Ferner RE, Lucas JD, O'Doherty MJ, Hughes RA, Smith MA, Cronin BF, Bingham J. J Neurol Neurosurg Psychiatry; 2000 Mar 10; 68(3):353-7. PubMed ID: 10675220 [Abstract] [Full Text] [Related]
19. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH. Eur J Surg Oncol; 2013 Jan 10; 39(1):46-52. PubMed ID: 23084090 [Abstract] [Full Text] [Related]
20. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Meany H, Dombi E, Reynolds J, Whatley M, Kurwa A, Tsokos M, Salzer W, Gillespie A, Baldwin A, Derdak J, Widemann B. Pediatr Blood Cancer; 2013 Jan 10; 60(1):59-64. PubMed ID: 22645095 [Abstract] [Full Text] [Related] Page: [Next] [New Search]